Association of polymorphisms in IL-8, MMP-1 and MMP-13 with the risk and prognosis of oral and oropharyngeal squamous cell carcinoma.

OBJECTIVE: This study investigated the risk and prognostic value of single nucleotide polymorphisms (SNP) inIL-8, MMP-1 and MMP-13 in oral and oropharyngeal squamous cell carcinomas (SCCs). DESIGN: SNPs rs2227532 and rs4073 inIL-8, rs2071230 and rs470558 in MMP-1, and rs2252070 in MMP-13 were genotyped in 125 oral and oropharyngeal SCC patients and 130 healthy controls, using TaqMan allelic discrimination assays. Multiple logistic regression models were used to explore the association between SNPs and cancer development, as well as SNP-SNP interaction and gene-environmental factor (GxE) interaction. Univariate and multivariate methods were applied for survival analyses. RESULTS: With exception of rs2227532, all the SNPs were in Hardy-Weinberg equilibrium in the control. No associations between rs4073 in IL-8 and rs2071230 and rs470558 in MMP-1 were observed, but rs2252070 in MMP-13, in the dominant model, was associated in a protective manner to oral and oropharyngeal SCC (OR: 0.20, 95% CI: 0.06-0.71, p = 0.007). All SNPs interact significantly with cigarette smoking and alcohol consumption on susceptibility to oral and oropharyngeal SCC, but they showed no influence on survival of the patients. CONCLUSIONS: Our results show that rs2252070 inMMP-13 may confer protection effect against oral and oropharyngeal SCC. In addition, the combined effects of IL-8 (rs4073), MMP-1 (rs2071230 and rs470558) and MMP-13 (rs2252070) with environmental carcinogens, such as tobacco and alcohol, are related to increased risk for oral and oropharyngeal SCC development.

Interstitial collagen turnover during airway remodeling in acute and chronic experimental asthma.

Asthma airway remodeling is characterized by the thickening of the basement membrane (BM) due to an increase in extracellular matrix (ECM) deposition, which contributes to the irreversibility of airflow obstruction. Interstitial collagens are the primary ECM components to be increased during the fibrotic process. The aim of the present study was to examine the interstitial collagen turnover during the course of acute and chronic asthma, and 1 month after the last exposure to the allergen. Guinea pigs sensitized to ovalbumin (OVA) and exposed to 3 further OVA challenges (acute model) or 12 OVA challenges (chronic model) were used as asthma experimental models. A group of animals from either model was sacrificed 1 h or 1 month after the last OVA challenge. Collagen distribution, collagen content, interstitial collagenase activity and matrix metalloproteinase (MMP)-1, MMP-13 and tissue inhibitor of metalloproteinase (TIMP)-1 protein expression levels were measured in the lung tissue samples from both experimental models. The results revealed that collagen deposit in bronchiole BM, adventitial and airway smooth muscle layers was increased in both experimental models as well as lung tissue collagen concentration. These structural changes persisted 1 month after the last OVA challenge. In the acute model, a decrease in collagenase activity and in MMP-1 concentration was observed. Collagenase activity returned to basal levels, and an increase in MMP-1 and MMP-13 expression levels along with a decrease in TIMP-1 expression levels were observed in animals sacrificed 1 month after the last OVA challenge. In the chronic model, there were no changes in collagenase activity or in MMP-13 concentration, although MMP-1 expression levels increased. One month later, an increase in collagenase activity was observed, although MMP-1 and TIMP-1 levels were not altered. The results of the present study suggest that even when the allergen challenges were discontinued, and collagenase activity and MMP-1 expression increased, fibrosis remained, contributing to the irreversibility of bronchoconstriction.

Primary ductal adenocarcinoma of the lacrimal gland: case report / Adenocarcinoma ductal primário da glândula lacrimal: relato de caso

A 78-year-old male patient presented with double vision, painless palpable mass under the right superolateral orbital rim, downward displacement and restricted adduction of the right eye. His visual acuity was 20/50 OD and 20/20 OS. Hertel exophthalmometry was 21 mm OD and 17 mm OS. Computed tomographic scans showed an infiltrative orbital mass with ill-defined, irregular margins, involving the lacrimal gland and the lateral rectus muscle. The patient underwent an anterior transcutaneous transseptal orbitotomy with incisional biopsy and surgical debulking. Histopathologic evaluation revealed primary ductal adenocarcinoma of the lacrimal gland. Following the metastatic work up, he underwent an eyelid-sparing orbital exenteration. Microscopically, the tumor elements were characterized by large polygonal cells with vesicular nuclei, prominent nucleoli and amphophilic cytoplasm. The tumor components comprised duct-type structures with papillary and cribriform patterns, surrounded by prominent basement membrane. The tumor cells were positive for cytokeratin-7, matrix metalloproteinase (MMP)-2, MMP-9, MMP-13 and proto-oncogene Her-2/neu, but negative for cytokeratin-5, cytokeratin-20, p63, prostate-specific antigen, S-100 protein and thyroid transcription factor. These histopathologic findings were compatible with poorly differentiated ductal adenocarcinoma of the lacrimal gland, T3N0M0. Twenty-four months after orbital exenteration, the patient was diagnosed with ipsilateral parotid gland and cervical lymph node metastases and died of disease.

Paciente do sexo masculino e com 78 anos de idade apresentou diplopia, massa palpável abaixo da margem orbitária direita, deslocamento inferior do bulbo ocular direito e limitação da adução do olho direito. A acuidade visual foi 20/50 OD e 20/20 OE. A exoftalmometria de Hertel foi 21 mm OD e 17 mm OE. Tomografia computadorizada mostrou uma massa orbitária, infiltrativa e com margens irregulares, envolvendo a glândula lacrimal e o músculo reto lateral. O paciente foi submetido a uma orbitotomia anterior com biópsia incisional. O exame histopatológico revelou adenocarcinoma ductal primário da glândula lacrimal. Em seguida, o paciente foi submetido a uma exenteração orbitária com preservação das pálpebras. Microscopicamente, os elementos tumorais foram caracterizados por células poligonais grandes com citoplasma anfofílico, núcleo vesicular e nucléolo proeminente. Os componentes tumorais incluíram estruturas ductais com padrões cribriforme e papilífero e cercadas por membrana basal proeminente. As células tumorais foram positivas para citoqueratina 7, metaloproteinase 2 da matriz, metaloproteinase 9 da matriz, metaloproteinase 13 da matriz e Her-2/neu, mas negativas para citoqueratina 5, citoqueratina 20, p63, antígeno prostático específico, proteína S-100 e fator de transcrição da tiroide. Estes achados histopatológicos foram compatíveis com o diagnóstico de adenocarcinoma ductal pouco diferenciado da glândula lacrimal, T3N0M0. Vinte e quatro meses após a exenteração orbitária, o paciente foi diagnosticado com metástases nos linfonodos cervicais ipsilaterais e na glândula parótida ipsilateral e faleceu.

Expressão de MMP-13 e ativação de vias de sinalização intracelular em dois modelos de doença periodontal induzida experimentalmente em ratos / MMP-13 expression and signaling pathways activated in two models of experimentally-induced periodontal disease in rats

A progressão da doença periodontal é marcada pela excessiva produção de citocinas que, por sua vez, promove o aumento de outros mediadores inflamatórios, entre os quais, de metaloproteinases de matriz (MMPs). MMP-13 é uma colagenase de regulação complexa que tem sido relacionada à degradação da matriz extracelular (ECM) e à reabsorção óssea em diversas condições inflamatórias, incluindo doença periodontal e artrite reumatóide. A regulação da expressão gênica requer a ativação de várias vias de sinalização através da interação de receptores celulares específicos a estímulos externos, como antígenos bacterianos e citocinas derivadas do hospedeiro. A complexidade da rede de citocinas estabelecida durante a progressão da doença periodontal depende das vias de sinalização ativadas, as quais são influenciadas pela natureza do estímulo extracelular. Considerando o papel fundamental das vias de sinalização no controle da expressão gênica de citocinas e a relevante atividade de MMP-13 na doença periodontal, este estudo avaliou a expressão de MMP-13 e as vias de sinalização ativadas durante o curso de dois modelos de doença periodontal induzida experimentalmente. A expressão de MMP-13 nos níveis de RNA mensageiro (mRNA) e proteína foram avaliados por RT-PCR e Western Blot, respectivamente. A cinética de ativação das vias de sinalização intracelular relacionadas à expressão de mediadores inflamatórios também foi verificada por Western Blot. Estes achados foram relacionados à severidade da reação inflamatória determinada por estereometria. Dois modelos experimentais foram usados: injeção de LPS e colocação de ligadura. Injeções de LPS de Eschericia coli foram realizadas na região palatina de molares superiores 2 vezes por semana (30 µg por aplicação). Ligaduras foram colocadas na região cervical dos primeiros molares inferiores. O grupo controle recebeu injeções de PBS (veículo) na gengiva palatina dos primeiros molares superiores, enquanto ligaduras não foram colocadas nos molares inferiores. Amostras foram coletadas 5, 15 e 30 dias após a indução da doença periodontal e processadas para extração de RNA total e proteína, assim como rotineiramente processadas para análise histológica/estereométrica. Um aumento significante da severidade da inflamação foi observado em ambos os modelos já no período de 5 dias. Entretanto, o modelo de ligadura mostrou uma diminuição da intensidade da inflamação aos 30 dias, que não foi observada no modelo de injeção de LPS. O perfil de expressão dos níveis de mRNA de MMP-13, assim como a cinética das vias de sinalização ativadas durante o curso da doença periodontal foram distintos segundo o modelo experimental mas, em geral, acompanharam a severidade do processo inflamatório. De forma interessante, não houve correlação entre os níveis protéicos e de mRNA de MMP-13 em ambos os modelos, sugerindo uma regulação pós­transcricional da expressão de MMP-13 in vivo. Além disso, p38 e ERK MAPkinases, assim como NF- B foram ativadas nos dois modelos de doença periodontal, embora com cinética distinta; enquanto ativação de STAT3 e STAT5 foi verificada apenas no modelo de ligadura. Estes achados sugerem uma ativação diferencial de receptores celulares em cada forma de indução da doença periodontal, o que determina diferenças temporais e qualitativas nas redes de sinalização intracelular ativadas e influencia a regulação da expressão gênica de MMP-13 em cada modelo experimental

The hallmark of destructive periodontal disease progression is the overproduction of cytokines which promotes the increased expression of other inflammatory mediators such as, MMPs. MMP-13 is a collagenase of complex gene regulation that has been implicated on ECM degradation and bone resorption in several inflammatory conditions, including periodontal disease and rheumatoid arthritis. Regulation of gene expression requires the activation of several signaling pathways through receptor-ligand binding of external stimuli represented by bacterial antigens and/or host-derived cytokines. The complexity of the cytokine network established during periodontal disease progression results from the signaling pathways activated, which are determined by the nature of external stimuli. Thus, considering the fundamental role of signaling pathways on regulation of cytokine gene expression and the relevant role of MMP-13 in periodontal disease, this study evaluated the expression of MMP-13 and the signaling pathways activated during the course of two experimentallyinduced periodontal disease models. Expression of MMP-13 at mRNA and protein levels was evaluated by reverse transcription polymerase chain reaction (RT-PCR) and Western Blot, respectively. The activation kinetics of some signaling pathways that are related to the expression of inflammatory mediators was also verified by Western Blot. The two experimental models used were: LPS injections and placement of ligatures. Bi-weekly injections of Eschericia coli LPS were done into the palatal aspect of upper molars (30 µg per injection). Ligatures were placed at the cervical portion of both lower first molars. The control animals received injections of PBS vehicle on the palatal gingiva of upper molars, whereas no ligatures were placed on the lower molars. Samples were collected 5, 15 and 30 days after beginning of periodontal disease induction and processed for extraction of total RNA and protein, as well as routinely processed for histology/estereometry. A significant increase on the severity of inflammation was observed in both experimental models already at the 5-day period. However, the ligature model presented a significant decrease on the intensity of inflammation at the 30-day period, which was not observed with the LPS injection model. MMP-13 expression profile, as well as the kinetic of signaling pathways activated during periodontal disease were somewhat different according to each experimental model, however paralleled the severity of inflammation. Interestingly, there was no transcription-translation coupling for MMP-13 in both models, suggesting a post­transcriptional regulation of MMP13 expression in vivo. Moreover, p38 and ERK MAPkinases, as well as NF-kB were activated in both periodontal disease models, however with different kinetics, whereas activation of STAT3 and STAT5 was verified only on the ligature model. These findings suggest a differential activation of cellular receptors in each model of experimentally-induced periodontal disease, which results in temporal and qualitative differences on the signaling network and influences MMP-13 gene regulation in each experimental model